BR112015014831A2 - partículas anidras de pó a líquido - Google Patents

partículas anidras de pó a líquido

Info

Publication number
BR112015014831A2
BR112015014831A2 BR112015014831A BR112015014831A BR112015014831A2 BR 112015014831 A2 BR112015014831 A2 BR 112015014831A2 BR 112015014831 A BR112015014831 A BR 112015014831A BR 112015014831 A BR112015014831 A BR 112015014831A BR 112015014831 A2 BR112015014831 A2 BR 112015014831A2
Authority
BR
Brazil
Prior art keywords
liquid
powder
particles
anhydrous particles
capsule
Prior art date
Application number
BR112015014831A
Other languages
English (en)
Inventor
Fassih Ali
Sun Ying
Original Assignee
Johnson & Johnson Consumer Companies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Companies Inc filed Critical Johnson & Johnson Consumer Companies Inc
Publication of BR112015014831A2 publication Critical patent/BR112015014831A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/621—Coated by inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Colloid Chemistry (AREA)

Abstract

resumo patente de invenção: "partículas anidras de pó a líquido". a presente invenção refere-se a um pó que compreende partículas de núcleo-cápsula que tem um tamanho médio de partícula menor que 1000 mícrons, cada partícula compreendendo: 1) núcleo líquido que é substancialmente isento de água e compreende um líquido polar tendo um percentual de polaridade de superfície de pelo menos 24%, e 2) cápsula compreendendo partículas hidrofóbicas.
BR112015014831A 2012-12-19 2013-12-17 partículas anidras de pó a líquido BR112015014831A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201213719649A 2012-12-19 2012-12-19
PCT/US2013/075714 WO2014099946A1 (en) 2012-12-19 2013-12-17 Anhydrous powder-to-liquid particles

Publications (1)

Publication Number Publication Date
BR112015014831A2 true BR112015014831A2 (pt) 2017-07-11

Family

ID=50931164

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015014831A BR112015014831A2 (pt) 2012-12-19 2013-12-17 partículas anidras de pó a líquido

Country Status (10)

Country Link
US (1) US20140170195A1 (pt)
EP (1) EP2934739B1 (pt)
KR (1) KR20150095924A (pt)
CN (1) CN104870083A (pt)
AU (1) AU2013362950B2 (pt)
BR (1) BR112015014831A2 (pt)
CA (1) CA2893972A1 (pt)
ES (1) ES2761450T3 (pt)
RU (1) RU2640184C2 (pt)
WO (1) WO2014099946A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112008001301T5 (de) 2007-05-14 2010-04-29 Reserach Foundation Of State University Of New York Induktion einer physiologischen Dispersions-Antwort in Bakterien-Zellen in einem Biofilm
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
WO2013006661A2 (en) 2011-07-06 2013-01-10 President And Fellows Of Harvard College Multiple emulsions and techniques for the formation of multiple emulsions
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US10005038B2 (en) 2014-09-02 2018-06-26 Lockheed Martin Corporation Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US10980919B2 (en) 2016-04-14 2021-04-20 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
TW201504140A (zh) 2013-03-12 2015-02-01 Lockheed Corp 形成具有均勻孔尺寸之多孔石墨烯之方法
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
EP3099645A4 (en) 2014-01-31 2017-09-27 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
CA2938273A1 (en) 2014-01-31 2015-08-06 Peter V. Bedworth Perforating two-dimensional materials using broad ion field
JP2017512129A (ja) 2014-03-12 2017-05-18 ロッキード・マーチン・コーポレーション 有孔グラフェンから形成された分離膜
US9474699B2 (en) 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
US9468606B2 (en) 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
BR112016029317A2 (pt) 2014-06-16 2017-08-22 Johnson & Johnson Consumer Inc composições e métodos para melhorar a aplicação tópica de um cosmético colorido
US20150359742A1 (en) * 2014-06-17 2015-12-17 Johnson & Johnson Consumer Inc. Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder
US20170224849A1 (en) * 2014-10-14 2017-08-10 President And Fellows Of Harvard College Microcapsules and uses thereof
WO2017004101A1 (en) * 2015-06-29 2017-01-05 The Procter & Gamble Company Skin care compositions comprising particles with nicotinamide riboside and methods of using the same
WO2017004102A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
WO2017023376A1 (en) 2015-08-05 2017-02-09 Lockheed Martin Corporation Perforatable sheets of graphene-based material
AU2016303049A1 (en) 2015-08-06 2018-03-01 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
CN105642203B (zh) * 2015-12-30 2017-12-26 西安科技大学 一种制备微胶囊的方法
JP6554540B2 (ja) 2016-01-11 2019-07-31 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 皮膚状態を処置するための組成物
CA3020880A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
JP2019519756A (ja) 2016-04-14 2019-07-11 ロッキード・マーチン・コーポレーション 欠陥形成または欠陥修復をその場で監視して制御する方法
WO2017180137A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Method for treating graphene sheets for large-scale transfer using free-float method
CA3020874A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Two-dimensional membrane structures having flow passages
FR3055813B1 (fr) * 2016-09-09 2020-06-26 H.E.F Poudre multimateriaux a grains composites pour la synthese additive
WO2018118635A1 (en) * 2016-12-23 2018-06-28 Avon Products, Inc. Stabilized topical compositions
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE
CN109485092B (zh) * 2017-09-11 2020-12-01 中南民族大学 一种二氧化钛自组装的微胶囊对氯酚类有机污染物的富集方法
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
WO2020198519A1 (en) * 2019-03-28 2020-10-01 Vantage Specialty Chemicals, Inc. Skin-enhancing development
CN110538470B (zh) * 2019-07-19 2021-04-27 泉州丽高食品有限公司 一种安全无毒的亮彩泡泡液
CN115843238A (zh) 2020-06-01 2023-03-24 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
KR102474794B1 (ko) * 2020-07-13 2022-12-06 (주)아크 약초 복합추출물을 함유하는 아토피 피부질환 개선용 동물 사료 첨가제 및 이의 제조방법
FR3115200B1 (fr) * 2020-10-21 2023-11-03 Oreal Composition cosmetique contenant des capsules de type cœur/enveloppe
KR102291413B1 (ko) * 2021-01-06 2021-08-20 주식회사 에스크컴퍼니 프로폴리스 추출물을 포함하는 생분해성 나노 입자 및 이의 제조방법
WO2022201164A1 (en) * 2021-03-25 2022-09-29 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) Active coating based on pickering emulsions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905694B1 (en) * 1997-05-12 2005-06-14 Hercules Incorporated Hydrophobically modified polysaccharide in personal care products
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
US7393548B2 (en) * 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
JP4514902B2 (ja) * 1999-08-24 2010-07-28 株式会社コーセー 含水粉末組成物及びその製造法並びに当該粉末組成物を含有する化粧料
US6413548B1 (en) * 2000-05-10 2002-07-02 Aveka, Inc. Particulate encapsulation of liquid beads
TWI411448B (zh) * 2007-12-27 2013-10-11 Avon Prod Inc 適合用於化妝品之光學模糊色素組合物
US20110124746A1 (en) * 2009-11-25 2011-05-26 National Starch & Chemical Company Alkenyl succinic acid anhydride half ester emulsifier
EP2343300A1 (en) * 2009-12-05 2011-07-13 Cognis IP Management GmbH Anionic isosorbide derivatives and their use (II)
DE102011077298A1 (de) * 2011-06-09 2012-12-13 Evonik Degussa Gmbh Kern-Hülle-Partikel mit einem hohen Gehalt an Glycerin, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
AU2013362950A1 (en) 2015-07-02
RU2015129542A (ru) 2017-01-26
AU2013362950B2 (en) 2017-04-13
US20140170195A1 (en) 2014-06-19
WO2014099946A1 (en) 2014-06-26
EP2934739B1 (en) 2019-10-02
KR20150095924A (ko) 2015-08-21
CA2893972A1 (en) 2014-06-26
RU2640184C2 (ru) 2017-12-26
CN104870083A (zh) 2015-08-26
ES2761450T3 (es) 2020-05-19
EP2934739A1 (en) 2015-10-28

Similar Documents

Publication Publication Date Title
BR112015014831A2 (pt) partículas anidras de pó a líquido
BR112016022159B8 (pt) Pó e método para melhorar a aplicação tópica de um agente de benefício ácido
BR112016022607B8 (pt) Pó e método para aprimorar a aplicação tópica de minoxidil
PH12014502660B1 (en) Tetrahydropyrazolopyrimidine compounds
MX2019005192A (es) Compuestos de quinolina selectivamente sustituida.
CA2934086C (en) Finisher composition comprising silicone microparticles and non-volatile oil
MX2016004629A (es) Compuestos de quinolina selectivamente sustituidos.
BR112013028449A2 (pt) composições compreendendo partículas de hidrogel
UY35281A (es) Composiciones que incluyen agentes para conferir carácter hidrofóbico y estabilizantes y métodos para elaborar y usar los mismos
BR112014029754A2 (pt) soluções de tensoativos contendo n-metil-n-oleilglucaminas e n-metil-n-c12-c14-acilglucaminas
BR112015016479A2 (pt) respirador de peça facial filtrante tendo uma vedação facial que compreende uma camada respirável de vapor d'água
BR112014012981A2 (pt) degradação eletrolítica controlada de ferramentas de fundo de poço
MX2016003660A (es) Conjugados de partícula similar a virus para el diagnóstico y tratamiento de tumores.
BR112014029781A2 (pt) soluções de tensoativos contendo n-metil-n-c8-c10-acilglucaminas e n-metil-n-c12-c14-acilglucaminas
MY170302A (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
BR112014033030A2 (pt) composição de leite de cal com partículas ultrafinas
BR112015013278A2 (pt) composição condicionadora de tecidos
BR112015012923A2 (pt) estruturação otimizada com agentes estruturantes curtos não poliméricos, cristalinos e contendo hidroxila
BR112016027653A2 (pt) Uso de uma partícula para absorver e reter compostos odoríferosos
BR112015020786A2 (pt) dispositivo de pulverização eletrostática e método para controlar dispositivo de pulverização eletrostática
EA201591433A1 (ru) Офтальмологические составы
BR102015006886B8 (pt) Composição tópicas que compreendem 4-hexilresorcinol e pós e uso
BR112014030704A2 (pt) partículas de vidro de baixa densidade com baixo teor de boro
BR112014007080A2 (pt) bucha para uso no fornecimento de proteção contra efeitos eletromagnéticos
EP2754432A3 (en) Aqueous compositions comprising polymer particles and low levels of clay

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements